Patents by Inventor Patrick J. Phillips

Patrick J. Phillips has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200268525
    Abstract: Bone implants, including methods of use and assembly. The bone implants, which are optionally composite implants, generally include a distal anchoring region and a growth region that is proximal to the distal anchoring region. The distal anchoring region can have one or more distal surface features that adapt the distal anchoring region for anchoring into iliac bone. The growth region can have one or more growth features that adapt the growth region to facilitate at least one of bony on-growth, in-growth, or through-growth. The implants may be positioned along a posterior sacral alar-iliac (“SAI”) trajectory. The implants may be coupled to one or more bone stabilizing constructs, such as rod elements thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: August 27, 2020
    Inventors: Ali H. MESIWALA, Mark A. REILEY, Paul M. SAND, Bret W. SCHNEIDER, Scott A. YERBY, Christopher I. SHAFFREY, Robert K. EASTLACK, Juan S. URIBE, Isador H. LIEBERMAN, Frank M. PHILLIPS, David W. POLLY, Phillip J. SINGER, Jeffrey B. PHELPS, Derek P. LINDSEY, Patrick KAHN, Nikolas F. KERR, Francois FOLLINI
  • Publication number: 20200261240
    Abstract: The present invention generally relates to bone implants. More specifically, the present invention relates to bone implants used for the fixation and or fusion of the sacroiliac joint and/or the spine. For example, a system for fusing and or stabilizing a plurality of bones is provided. The system includes an implant structure having a shank portion, a body portion and a head portion. The body portion is coupled to the shank portion and is configured to be placed through a first bone segment, across a bone joint or fracture and into a second bone segment. The body portion is configured to allow for bony on-growth, ingrowth and through-growth. The head portion is coupled to the proximal end of the shank portion and is configured to couple the shank portion to a stabilizing rod. Methods of use are also disclosed.
    Type: Application
    Filed: February 14, 2019
    Publication date: August 20, 2020
    Inventors: Ali H. MESIWALA, Mark A. REILEY, Paul M. SAND, Bret W. SCHNEIDER, Scott A. YERBY, Christopher I. SHAFFREY, Robert K. EASTLACK, Juan S. URIBE, Isador H. LIEBERMAN, Frank M. PHILLIPS, David W. POLLY, Phillip J. SINGER, Jeffrey B. PHELPS, Derek P. LINDSEY, Patrick KAHN, Nikolas F. KERR
  • Patent number: 10715879
    Abstract: Synchronizing ancillary data to content including audio includes obtaining a representation of the content's audio and ancillary data pegged to instants in the representation of the content's audio, and aligning the representation of the content's audio to the content's audio to synchronize the ancillary data pegged to the instants in the representation of the content's audio to the content.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: July 14, 2020
    Assignee: Source Digital, Inc.
    Inventors: Timothy J. Carroll, Henry Lawrence Frecon, III, Patrick Clay Greene, Michael Eric Phillips
  • Publication number: 20200171020
    Abstract: The present disclosure relates generally to certain 6-azabenzimidazole compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions disclosed herein may be used for the treatment or prevention of diseases, disorders, or infections modifiable by hematopoietic progenitor kinase 1 (HPK1) inhibitors, such as HBV, HIV, cancer, and/or a hyper-proliferative disease.
    Type: Application
    Filed: October 30, 2019
    Publication date: June 4, 2020
    Inventors: Gayatri Balan, Mark J. Bartlett, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway, Jennifer L. Cosman, Rao V. Kalla, Musong Kim, Seung H. Lee, Jennifer R. Lo, Jennifer A. Loyer-Drew, Scott A. Mitchell, Thao D. Perry, Gary B. Phillips, Patrick J. Salvo, Joshua J. Van Veldhuizen, Suet C. Yeung, Jeff Zablocki
  • Patent number: 10592314
    Abstract: A message broker configured to handle messages received from a plurality of client applications comprises a plurality of message queues that are each associated with a different task. A first synchronous message is received at a first message queue from a first client application. A determination is made that at a time the first synchronous message is received there is an earlier-received message from a different client application waiting in the first message queue. In response to the determination, the first synchronous message is coalesced with the earlier-received message such that a task associated with the first message queue is executed only once for both messages and a notice of the execution is returned to the first client application.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: March 17, 2020
    Assignee: International Business Machines Corporation
    Inventors: William F. Phillips, Victor M. Lourenco, Patrick J. Clas
  • Patent number: 10436117
    Abstract: A fuel injection system for a gas turbine engine includes a vane in an airflow path within the gas turbine engine, the vane includes an air channel with an outlet in communication with the airflow path; and a fuel nozzle within the vane operable to inject fuel into the air channel to at least partially premix and prevaporize the fuel with a secondary airflow from within the vane in the air channel prior to entry into the airflow path through the outlet. A method of injecting fuel within a gas turbine engine includes at least partially premixing and prevaporizing fuel with a secondary airflow from within a vane in an air channel within the vane, the vane within an airflow path of the gas turbine engine.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: October 8, 2019
    Assignee: United Technologies Corporation
    Inventors: Jeffery A. Lovett, Darin A. Knaus, Scott D. Phillips, Daniel J. Micka, Patrick Magari
  • Patent number: 10397663
    Abstract: Synchronizing ancillary data to content including audio includes obtaining a representation of the content's audio and ancillary data pegged to instants in the representation of the content's audio, and aligning the representation of the content's audio to the content's audio to synchronize the ancillary data pegged to the instants in the representation of the content's audio to the content.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: August 27, 2019
    Assignee: Source Digital, Inc.
    Inventors: Timothy J. Carroll, Henry Lawrence Frecon, III, Patrick Clay Greene, Michael Eric Phillips
  • Publication number: 20190232092
    Abstract: Apparatus and methods for creating tissue necrosis include an energy delivery apparatus that can be positioned adjacent a target treatment site such as a vessel without direct contact with the treatment site tissue. Collimated energy is then directed to the vessel to create necrotic regions in the tissue. Exemplary use in renal vessels creates necrotic regions in adjacent nerves which can alleviate hypertension in a patient.
    Type: Application
    Filed: March 28, 2019
    Publication date: August 1, 2019
    Inventors: Michael J. PEDERSON, Patrick J. PHILLIPS, John P. MADDEN, Michael J. HORZEWSKI
  • Publication number: 20190222876
    Abstract: A method for a media environment driven content distribution platform includes obtaining synchronization data derived from the content and ancillary data pegged to instants in the synchronization data derived from the content, and communicating the synchronization data derived from the content and the ancillary data pegged to the instants in the synchronization data derived from the content such that subsequent alignment of the synchronization data derived from the content to the content synchronizes the ancillary data pegged to the instants in the synchronization data derived from the content to the content.
    Type: Application
    Filed: April 10, 2017
    Publication date: July 18, 2019
    Inventors: Henry Lawrence Frecon, III, Patrick Clay Greene, Michael Eric Phillips, Timothy J. Carroll
  • Patent number: 10286231
    Abstract: Apparatus and methods for creating tissue necrosis include an energy delivery apparatus that can be positioned adjacent a target treatment site such as a vessel without direct contact with the treatment site tissue. Collimated energy is then directed to the vessel to create necrotic regions in the tissue. Exemplary use in renal vessels creates necrotic regions in adjacent nerves which can alleviate hypertension in a patient.
    Type: Grant
    Filed: January 30, 2013
    Date of Patent: May 14, 2019
    Assignee: VytronUS, Inc.
    Inventors: Michael J. Pederson, Patrick J. Phillips, John P. Madden, Michael J. Horzewski
  • Publication number: 20140046313
    Abstract: Apparatus and methods for creating tissue necrosis include an energy delivery apparatus that can be positioned adjacent a target treatment site such as a vessel without direct contact with the treatment site tissue. Collimated energy is then directed to the vessel to create necrotic regions in the tissue. Exemplary use in renal vessels creates necrotic regions in adjacent nerves which can alleviate hypertension in a patient.
    Type: Application
    Filed: January 30, 2013
    Publication date: February 13, 2014
    Applicant: VytronUS, Inc.
    Inventors: Michael J. Pederson, Patrick J. Phillips, John P. Madden, Michael J. Horzewski
  • Patent number: 8491483
    Abstract: Highly specific measurements of flow in vessels, such as the coronary artery, can be obtained by processing cubic fundamental information. By showing flow in vessels with a high degree of contrast-to-tissue specificity, ultrasound based 3D contrast agent based coronary artery angiograms may be possible. Measurement and display of the velocity of agent from the cubic fundamental signal is provided simultaneously with display of cubic fundamental energy, such as providing a display map indexed by both energy and velocity. High pulse repetition frequency (PRF) for cubic fundamental detection in conjunction with long velocity measurement intervals may increase low velocity sensitivity and measurement precision. Pulsed wave (PW) Doppler may be improved by using a cubic fundamental sensitive pulse sequence.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: July 23, 2013
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Ismayil M. Guracar, James E. Chomas, Patrick J. Phillips
  • Patent number: 8177719
    Abstract: Highly specific measurements of flow in vessels, such as the coronary artery, can be obtained by processing cubic fundamental information. By showing flow in vessels with a high degree of contrast-to-tissue specificity, ultrasound based 3D contrast agent based coronary artery angiograms may be possible. Measurement and display of the velocity of agent from the cubic fundamental signal is provided simultaneously with display of cubic fundamental energy, such as providing a display map indexed by both energy and velocity. High pulse repetition frequency (PRF) for cubic fundamental detection in conjunction with long velocity measurement intervals may increase low velocity sensitivity and measurement precision. Pulsed wave (PW) Doppler may be improved by using a cubic fundamental sensitive pulse sequence.
    Type: Grant
    Filed: June 14, 2005
    Date of Patent: May 15, 2012
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Ismayil M. Guracar, James E. Chomas, Patrick J. Phillips
  • Patent number: 7998076
    Abstract: Contrast agents are characterized with ultrasound. Flowing or unbound contrast agents are distinguished automatically from bound or relatively stationary contrast agents. The bound or relatively stationary contrast agents are highlighted on a display. A processor distinguishes different types of contrast agents or contrast agents in different binding states with relative signal strength or velocity. Attached contrast agents are differentiated from phagocytosed contrast agents. Monitoring absolute signal strength as a function of time may indicate binding. Any one or more of these features may be used.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: August 16, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Patrick J. Phillips, James E. Chomas, Ismayil M. Guracar
  • Patent number: 7993273
    Abstract: System parameters for contrast agent medical imaging are conveniently set. A simplified contrast agent configuration is provided where an appropriate contrast agent detection technique and/or contrast agent imaging parameters are achieved consistently and more often then exists with current methods. Examination workflow is improved for contrast agent studies by offering one contrast agent imaging mode or configuration that is dynamically determined and optimized based on the user's selected transmit level and/or a real-time measurement of the contrast agent signals. A simplified user interface provides one contrast agent imaging mode without a need to switch between multiple modes or contrast agent detection techniques and associated contrast agent imaging parameters. The contrast agent detection technique and imaging parameters are adjusting or selected based on changes in the transmit levels for contrast agent imaging.
    Type: Grant
    Filed: May 29, 2008
    Date of Patent: August 9, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Patrick J. Phillips, Ismayil M. Guracar
  • Patent number: 7946990
    Abstract: A method is provided to improve the frame-rate in color-flow ultrasound imaging using simultaneous spatially-distinct transmit beams with one or more frequency bands per transmit beam. Pulses of different center frequencies are used simultaneously in different (lateral and/or elevational) directions, thereby reducing the scanning time and improving the frame-rates. Optionally, a multi-modal pulse is used, and flow is estimated separately for the different frequencies. The flow estimates for these pulses are appropriately combined to improve low-velocity sensitivity and to reduce aliasing. A flow sample count with two or more different pulse repetition intervals can be used to further improve low-flow sensitivity and minimize aliasing.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: May 24, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Seshadri Srinivasan, Patrick J. Phillips, Charles E. Bradley
  • Patent number: 7887484
    Abstract: Velocity scale is automatically determined for ultrasound imaging. Receive signals corresponding to different pulse repetition intervals are used to estimate velocities. The different velocities are used to determine the velocity scale. For example, the different pulse repetition intervals are obtained by selecting different sets of signals from a group of signals for a scan line. As another example, the different pulse repetition intervals are obtained by transmitting for a scan line with changing, such as increasing, pulse repetition intervals. The lower pulse repetition interval of a pair of intervals associated with a sign change in the phase is used for the velocity scale. In yet another example, at least two demodulation frequencies are used for a broadband transmit in at least two sets, each set with a different pulse repetition interval. Velocities are estimated for a greater number of pulse repetition intervals than transmitted using the broadband pulses.
    Type: Grant
    Filed: August 12, 2005
    Date of Patent: February 15, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Seshadri Srinivasan, Bhaskar Ramamurthy, Ismayil M. Guracar, Patrick J. Phillips, Rickard C. Loftman
  • Patent number: 7837626
    Abstract: Contrast agents are manipulated with acoustic radiation force while ultrasound imaging. Continuous waves for acoustic radiation force are transmitted. Substantially simultaneously, pulsed waves for imaging are transmitted. Low mechanical index continuous and pulsed waves may be used to increase binding efficiency of drug containing contrast agents with the tissue for treatment. Various techniques may be used to minimize the effect of the continuous waves on imaging with the pulsed waves. The acoustic radiation force may be transmitted with an amplitude profile and/or unfocused or defocused.
    Type: Grant
    Filed: August 5, 2005
    Date of Patent: November 23, 2010
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: James E. Chomas, Ismayil M. Guracar, Patrick J. Phillips, John D. Marshall
  • Patent number: 7775981
    Abstract: A transmit sequence for contrast agent imaging that improves sensitivity and minimizes image artifacts. The number of pulses and the interleaving of spatially distinct pulses between spatially co-linear pulses are selected such that a substantially similar pulse sequence for substantially each line in a scanned region is generated. A collateral pulse from a different scan line is interleaved between at least two imaging pulses along a scan line of interest. Such pulse sequences provide sensitive contrast agent imaging with minimized spatial variation. In another aspect, responsive signals representing the first and second scan lines are obtained. Intensities associated with the signals are determined. The intensities associated with the first scan line are compared to a value.
    Type: Grant
    Filed: September 6, 2000
    Date of Patent: August 17, 2010
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Ismayil M. Guracar, Patrick J. Phillips
  • Patent number: 7591788
    Abstract: System parameters for contrast agent medical imaging are conveniently set. A simplified contrast agent configuration is provided. One contrast agent imaging mode or configuration is dynamically determined and optimized based on the user's selected transmit level and/or a real-time measurement of the contrast agent signals. A simplified user interface provides one contrast agent imaging mode without a need to switch between multiple modes or contrast agent detection techniques and associated contrast agent imaging parameters. The contrast agent detection technique and imaging parameters are adjusted or selected based on changes in the transmit levels for contrast agent imaging. Appropriate contrast agent detection techniques and imaging parameters are selected for each given transmit level without the user having to switch the mode or configuration of the system during an imaging session.
    Type: Grant
    Filed: August 19, 2003
    Date of Patent: September 22, 2009
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Patrick J. Phillips, Ismayil Guracar